Newsroom
News Releases
News releases issued by Kyowa Kirin are intended to inform stakeholders of information related to the company's business in a fair manner. Though it may include information concerning pharmaceutical products (including products under development) , it is not for the purpose of promoting, advertising or medical advice.
Latest News
-
The KIRIN HEALTH INNOVATION FUND Invests in ThinkCyte, Developer Of AI-based Next-generation Cell Analysis And Sorting Technologies
September 3, 2024
［Health Science domain］
-
The KIRIN HEALTH INNOVATION FUND Invests In Rhelixa, A Leading Epigenome Analysis Company
August 23, 2024
［Health Science domain］
Kirin Holdings' and Domestic Group Companies' News
-
The KIRIN HEALTH INNOVATION FUND Invests In Sagri, A Company That Uses Satellite Data And AI Technology To Solve Agricultural Issues
August 9, 2024
［Health Science domain］
-
Kyowa Hakko Bio’s 2’-Fucosyllactose Receives Novel Food Approval in the EU
August 8, 2024
［Health Science domain］
-
LC-Plasma Product Series Sales Increase 40% From January To June Of This Year
August 5, 2024
［Health Science domain］
-
Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
June 14, 2024
［Health Science domain］
-
Notice Regarding Price Revision For Kirin Beverage Products
May 29, 2024
［Food & Beverages domain］
Overseas Group Companies' News
-
Kyowa Hakko Bio Partners with the Agency for Science, Technology and Research (A*STAR) to Study Human Milk Oligosaccharides (HMOs)
January 16, 2024
［Health Science domain］
-
Kyowa Hakko USA Launches First Supplement Containing IMMUSE™ in Mexico
September 21, 2023
［Pharmaceuticals domain］
